Cargando…
cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice
Increasing preclinical and clinical results have demonstrated that mRNA vaccines efficiently prevent infectious diseases and are safe in animal models and humans. In this study, we fabricated a multivalent influenza mRNA lipid nanoparticle (LNP) vaccine with mRNAs of hemagglutinins from influenza H1...
Autores principales: | Zhu, Wandi, Wei, Lai, Dong, Chunhong, Wang, Ye, Kim, Joo, Ma, Yao, Gonzalez, Gilbert X., Wang, Bao-Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668623/ https://www.ncbi.nlm.nih.gov/pubmed/36420215 http://dx.doi.org/10.1016/j.omtn.2022.10.024 |
Ejemplares similares
-
cGAMP the travelling messenger
por: Blest, Henry T. W., et al.
Publicado: (2023) -
cGAMP/Saponin Adjuvant Combination Improves Protective Response to Influenza Vaccination by Microneedle Patch in an Aged Mouse Model
por: Vassilieva, Elena V., et al.
Publicado: (2021) -
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
por: Chauveau, Lise, et al.
Publicado: (2021) -
Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery
por: He, Yanpu, et al.
Publicado: (2020) -
The Signaling Pathway That cGAMP Riboswitches Found: Analysis and Application of Riboswitches to Study cGAMP Signaling in Geobacter sulfurreducens
por: Tan, Zhesen, et al.
Publicado: (2022)